Abstract-The Ca 2ϩ -independent portion of transient outward K ϩ current (I to ) exhibits a transmural gradient in ventricle. To investigate control mechanisms for this gradient, we studied canine epicardial and endocardial ventricular myocytes with use of the whole-cell patch-clamp technique. I to was larger in amplitude, had a more negative voltage threshold for activation, and had a more negative midpoint of inactivation in epicardium. Recovery from inactivation was Ͼ10-fold slower in endocardium. Incubation of epicardial myocytes with angiotensin II for 2 to 52 hours altered I to to resemble unincubated endocardium and reduced the amplitude of the phase 1 notch of the action potential. In contrast, incubation of endocardial myocytes with losartan for 2 to 52 hours altered I to to resemble unincubated epicardium and induced a phase 1 notch in the action potential. With RNase protection assays, we determined that incubations with angiotensin II or losartan did not alter mRNA levels for either Kv4.3 or Kv1.4; thus, a change in the ␣ subunit for I to is unlikely to be responsible. To test whether posttranslational modification produced the effects of angiotensin II, we coexpressed Kv4.3 and the angiotensin II type 1a receptor in Xenopus oocytes. Incubation with angiotensin II increased the time constant for recovery from inactivation of the expressed current by 2-fold with an incubation time constant of 3.7 hours. No effect on activation or inactivation voltage dependence was observed. These results demonstrate that the properties of I to in endocardium and epicardium are plastic and likely under the tonic-differing influence of the reninangiotensin system. (Circ Res. 2000;86:1062-1068.) Key Words: angiotensin Ⅲ epicardium Ⅲ endocardium Ⅲ current D ifferences in the action potential duration of myocytes from the endocardium (ENDO) and the epicardium (EPI) of the canine heart contribute to the morphology and polarity of the T wave of the ECG. 1,2 The ionic currents responsible for these differences are determinants of the T wave. One major difference between EPI and ENDO myocyte ion currents is in the Ca 2ϩ -independent transient outward current (referred to here as I to ). Previous investigations have demonstrated a lower density and slower recovery from inactivation in ENDO compared with in EPI. 3, 4 We recently identified the molecular basis of I to in canine ventricle as a member of the Shaker family of K channels, Kv4.3. 5 Among the potential modulators of the T wave is the renin-angiotensin system and its active hormone, angiotensin II (Ang II). 6 Ang II has direct actions on cardiac membrane currents, increasing chloride current 7 and decreasing Na ϩ /K ϩ exchange current 8 in rabbit ventricular myocytes. These actions occur through the Ang II type 1 (AT 1 ) receptor, which is prevalent in cardiac tissues of many species. 9,10 Not only is the AT 1 receptor present in heart, but also an autocrine renin-angiotensin system is present in rat ventricular myocytes. [11] [12] [13] This suggests that mammalian cardiac myocytes or nonmyocyte elements in mammalian hearts can produce this hormone, which modulates repolarizing currents.
D
ifferences in the action potential duration of myocytes from the endocardium (ENDO) and the epicardium (EPI) of the canine heart contribute to the morphology and polarity of the T wave of the ECG. 1, 2 The ionic currents responsible for these differences are determinants of the T wave. One major difference between EPI and ENDO myocyte ion currents is in the Ca 2ϩ -independent transient outward current (referred to here as I to ). Previous investigations have demonstrated a lower density and slower recovery from inactivation in ENDO compared with in EPI. 3, 4 We recently identified the molecular basis of I to in canine ventricle as a member of the Shaker family of K channels, Kv4.3. 5 Among the potential modulators of the T wave is the renin-angiotensin system and its active hormone, angiotensin II (Ang II). 6 Ang II has direct actions on cardiac membrane currents, increasing chloride current 7 and decreasing Na ϩ /K ϩ exchange current 8 in rabbit ventricular myocytes. These actions occur through the Ang II type 1 (AT 1 ) receptor, which is prevalent in cardiac tissues of many species. 9, 10 Not only is the AT 1 receptor present in heart, but also an autocrine renin-angiotensin system is present in rat ventricular myocytes. [11] [12] [13] This suggests that mammalian cardiac myocytes or nonmyocyte elements in mammalian hearts can produce this hormone, which modulates repolarizing currents.
In the present study, we first describe the properties of I to in canine EPI and ENDO, outlining differences in both current density and gating properties. We then demonstrate that the differences between these 2 tissues are entirely plastic; that is, long-term exposure of EPI to Ang II or of ENDO to the AT 1 receptor blocker losartan can convert properties of I to of either region into those of the other, thereby providing a basis for an altered transmural gradient of repolarization in the ventricle and resultant Twave changes.
according to the trituration method developed in our laboratory. 14 Cells were stored in KB solution (which contained [in mmol/L] KCl 83, K 2 HPO 4 30, MgSO 4 5, Na-pyruvic acid 5, ␤-OH butyric acid [Na-salt] 5, taurine 20, glucose 10, EGTA 0.5, HEPES 5, Na 2 ATP 5, and creatine 5, titrated to pH 7.2 with KOH) 15 at room temperature for at least 1 hour before electrophysiological experiments. Cells were incubated in KB solution at room temperature the first day of experiments (2 to 5 hours) and then at 4°C for experimentation on days 2 and 3 (6 to 52 hours). Ang II and saralasin were purchased from Sigma Chemical Co, and losartan was kindly provided by Merck.
Measurement of I to , Action Potentials, and Data Analysis
Isolated cells were maintained at 32°to 35°C (Ϯ0.5°C in each experiment). 16 I to and action potentials were recorded with use of the whole-cell patch-clamp technique. I to was defined as the difference between the peak value and the current level at the end of a 300-or 400-ms pulse. The threshold was the most negative test voltage that elicited an I to of Ͼ10 pA. The pipettes were filled with solution containing (in mmol/L) NaCl 6, K-aspartate 130, MgCl 2 2, CaCl 2 5, EGTA 11, Na 2 ATP 2, Na-GTP 0.1, Na-cAMP 0.2, and HEPES 10 (pH adjusted to 7.2 with KOH). The external solution contained (in mmol/L) NaCl 137.7, NaOH 2.3, MgCl 2 1, glucose 10, HEPES 5, KCl 5.4, CaCl 2 1.8, MnCl 2 2, and CdCl 2 0.2, pH 7.4. The liquid junction potential of Ϫ11 mV between the electrode tip and the cell interior (cell interior negative) was not corrected. 17 Mn 2ϩ and Cd 2ϩ were used to block Ca 2ϩ currents, which can obscure I to activation.
RNase Protection Assays
ENDO and EPI myocytes were incubated for 24 hours either with or without 2 mol/L Ang II (EPI) or 2 mol/L losartan (ENDO). mRNA was isolated with the use of paramagnetic poly(dT) beads (Dynal). RNA probes for Kv1.4 and Kv4.3 were prepared as described previously. 5 RNase protection assays were performed and quantified as described previously. 5
Heterologous Expression in Oocytes
Oocytes were prepared from Xenopus laevis as previously described. 5 Oocytes were injected with 50 nL Kv4.3 mRNA or an equimolar ratio of Kv4.3 and AT 1a mRNA. Injected oocytes were incubated at 18°C for 24 to 48 hours. In the study of Ang II treatment, oocytes were then incubated in OR3 5 solution containing 4 mol/L Ang II for 25 to 32 hours at 18°C before testing. Oocytes were voltage-clamped with the use of a 2-microelectrode voltage clamp. The extracellular recording solution was OR2. 5 Data are presented as meanϮSEM. Statistical significance was tested with Student's t tests. PϽ0.05 was considered statistically significant.
An expanded Materials and Methods section is available online at http://www.circresaha.org.
Results

Gating Properties of I to in ENDO Differ From Those in EPI
We began our investigation by characterizing I to in both ENDO and EPI ventricular myocytes. We first examined the voltage dependence of activation. We held the cells at Ϫ65 mV and first briefly depolarized (5 ms) to Ϫ45 mV to inactivate I Na and then depolarized to voltages from Ϫ40 to ϩ50 mV in 10-mV increments for 300 ms. The average threshold for first observation of transient outward current (see Materials and Methods for definition) was Ϫ25Ϯ2 mV (nϭ24) in EPI myocytes and 4Ϯ3 mV (nϭ15) in ENDO myocytes. As previously reported, 3 the amplitude of transient outward current is also larger in the EPI myocyte. The larger I to was determined in the Table by measuring the dependence of the transient outward conductance on voltage, which increases almost 4-fold more rapidly in EPI than in ENDO. Our results are reported normalized to capacitance. The average capacitance was 125Ϯ26 pF (nϭ20) in ENDO myocytes and 104Ϯ8 pF (nϭ26) in EPI myocytes.
We also examined the voltage dependence of inactivation of I to . We held the membrane at Ϫ65 mV and used a 3-pulse protocol. We first depolarized for 5 ms to Ϫ45 mV to inactivate I Na and then used a first (conditioning) pulse, which either depolarized or hyperpolarized for 2 seconds to bring the membrane to a new starting value for inactivation; with the second (test) pulse, we depolarized to ϩ10 mV for 400 ms (see Figure 1A) . I to amplitude normalized to I to for the most negative conditioning pulse is plotted against each conditioning voltage in Figure 1B , along with the fits of a Boltzmann 2-state model. I to exhibited a more positive midpoint of inactivation in ENDO myocytes and a reduction in steepness of the inactivation curve.
The time constant of inactivation of I to did not differ between ENDO and EPI. We then used a 2-pulse protocol to investigate the kinetics of recovery from inactivation. The cycle length was 8 seconds. The first depolarizing pulse of 300 ms in duration was applied from the holding potential of Ϫ65 mV to the test potential of ϩ5 mV EPI, or ϩ15 mV ENDO, to activate a measurable I to ; then, a variable interval at the holding potential was allowed for recovery from inactivation, followed by a second identical test pulse. Data are provided in Figures 1C and 1E for EPI and ENDO myocytes, respectively. I to recovered from inactivation at a
I to Plasticity in ENDO and EPI
EPI EPIϩAng II ENDO ENDOϩLosartan
Conductance-voltage slope, pS/(pF/mV) 2.3 0.9 0.6 2.1* 
Incubation of EPI Myocytes With Ang II Alters I to so That Its Gating Properties Resemble Those Found in ENDO
Superfusion of EPI myocytes with 1 mol/L Ang II for 5 to 20 minutes induced no change in the activation or density of I to (nϭ8). Recovery from inactivation was also studied in 4 myocytes, where no change was observed. We then studied the effects of chronic exposure of EPI myocytes to Ang II by storing myocytes for a period of 2 to 52 hours in KB medium containing 0.5 to 2 mol/L Ang II, after which electrophysiological studies of I to were performed in the absence of Ang II at 32°to 35°C. We also incubated EPI myocytes from the same animals in the same storage solution and for the same time period but without Ang II. These myocytes showed no significant difference from the control values for EPI myocytes studied acutely. Figure 2A provides sample data from EPI myocytes incubated in control solution or with Ang II for 24 hours ( Figure 2B ). Figure 2C clearly shows the current density is reduced by Ang II and that the activation has been shifted to more positive potentials (see Table) .
We also examined the steady-state voltage dependence of inactivation and the recovery from inactivation in the Ang II-incubated myocytes; the results are presented in Figure 3 . Steady-state inactivation is shifted to more positive potentials, and the recovery from inactivation is dramatically slowed by incubation with Ang II. Effect of chronic exposure to Ang II (AII) on I to activation and current density in EPI. A, Control myocyte, incubated for 24 hours. I to is activated at Ϫ30 mV, and the current amplitude is increased with further membrane depolarizations up to ϩ50 mV. B, After incubation of another myocyte with Ang II for 24 hours, identical depolarizing pulses to those used in A were applied. I to begins to activate at Ϫ10 mV, and its amplitude is increased with further depolarization up to ϩ50 mV. C, Averaged results before and after incubation; current-voltage relationship shows the averaged current density of I to in EPI myocytes pretreated with Ang II is reduced. The effects of Ang II incubation on EPI I to were prevented when the AT 1 receptor blocker losartan (1 mol/L) was included with Ang II in the incubate.
Incubation of ENDO Myocytes With the AT 1 Receptor Blocker Losartan Alters I to Such That Its Properties Resemble Those of EPI
Given the effects of incubation with Ang II on EPI myocytes and the existence of an autocrine renin-angiotensin system, we explored the possibility that blockade of the normal Ang II pathway via the AT 1 receptor might modulate I to in ENDO. We first acutely exposed ENDO myocytes to losartan (1 mol/L). No acute effects on I to activation or density (5 myocytes) or recovery from inactivation (3 myocytes) were observed (data not shown).
We next incubated ENDO myocytes for 2 to 52 hours with 1 to 2 mol/L losartan in the same incubation solution as was used for EPI myocytes. We also examined ENDO myocytes stored in the same incubate without added losartan. We observed no change in the properties of I to from those of unincubated ENDO myocytes. The effects of losartan on I to amplitude and the voltage dependence of activation are presented in Figure 4 . I to is increased and the voltage dependence of activation is shifted to more negative potentials (see the Table) , similar to control EPI.
We next examined the voltage dependence of inactivation and the time course of recovery from inactivation in the losartan-incubated ENDO myocytes. Figure 5 illustrates the results. Steady-state inactivation shifts to more negative potentials, and the time constant for recovery from inactivation becomes much faster.
The Table compares properties of I to in ENDO myocytes incubated with losartan with unincubated ENDO and EPI myocytes. Losartan incubation converts most properties of I to in ENDO myocytes to resemble those of unincubated EPI myocytes.
Two additional control experiments were performed. In 1 experiment (nϭ10), EPI was incubated for 2 to 52 hours with losartan, and in the other (nϭ5), ENDO was incubated with Ang II for the same time period. No effect was observed of either incubation on I to (data not shown).
Action Potential Notch Is Influenced by Ang II
I to is responsible for phase 1 rapid repolarization. Given the effects of Ang II and of losartan on EPI and ENDO I to , respectively, changes in the action potential contour might be expected. We recorded action potentials from 11 control EPI and 10 control ENDO myocytes as well as from 5 EPI myocytes incubated for 24 hours with 1 mol/L Ang II and from 6 ENDO myocytes incubated for 24 hours with 1 mol/L losartan. Representative results are illustrated in Figure 6 . Control EPI action potentials always demonstrated a notch, whereas control ENDO action potentials did not (a difference noted previously by others 1 ). EPI myocyte incubation with Ang II resulted in loss of the notch, whereas ENDO myocyte incubation with losartan produced a notch. These changes are consistent with the changes in I to that we described earlier.
mRNA levels for Kv4.3 and Kv1.4
The patch-clamp results revealed changes in I to induced by incubation with either Ang II (EPI) or losartan (ENDO). However, they do not provide a mechanism for the observed effects. One possibility is a change in the molecular correlate of the current. We previously demonstrated that Kv4.3 underlies I to in the canine ventricle. However, Kv1.4 is present in canine myocytes and recovers from inactivation much more slowly. We therefore examined the effects of 
Heterologous Expression of Kv4.3 With the AT 1 Receptor in X laevis Oocytes
If a change in the molecular correlate of I to does not occur, possibly the changes could be induced by posttranslational modification of the existing protein. To test this hypothesis, we heterologously expressed the dominant molecular correlate of canine I to , Kv4.3, in X laevis oocytes along with the AT 1a receptor. Figure 7 shows the results of our study of the effects of incubation with 4 mol/L Ang II for up to 32 hours on recovery from inactivation with the following protocol. Membrane potential was depolarized to Ϫ20 mV for 600 to 900 ms from a holding potential of Ϫ90 mV to completely inactivate Kv4.3 current. The recovery potential was Ϫ100 mV followed by test steps to Ϫ20 mV at various intervals. The recovery kinetics were slower for the treated oocyte (ϭ361 ms) compared with the control oocyte (ϭ141 ms) ( Figures   7A and 7B) . The average Ϸ2-fold slowing of the time constant for recovery from inactivation is provided in Figure  7C for all oocytes studied. Figure 7C also illustrates that this effect is not observed in the absence of either Ang II or the AT 1a receptor. Figure 7D illustrates the time course of the change in recovery from inactivation after incubation with Ang II. The time constant is 3.7 hours.
Although an effect is observed on recovery from inactivation, there was no effect of incubation with Ang II on either the voltage dependence of inactivation or activation (data not shown).
Discussion
In agreement with previous studies, 3, 4 we found a smaller density and a slower recovery from inactivation of I to in ENDO than in EPI. We also observed a more positive threshold for I to activation in ENDO. The smaller current density, more positive activation, and slower recovery from inactivation all contribute to the absence of a notch in the ENDO action potential during steady-state ventricular beating. One additional difference between these 2 tissue types is the voltage dependence of I to inactivation, which is more positive in ENDO.
The critical findings in our study were that, first, Ang II converts many of the properties of EPI I to to those normally seen in ENDO, and second, losartan converts many of the properties of ENDO I to to those normally seen in EPI. Important to these observations is that neither exposure of ENDO to agonist nor exposure of EPI to antagonist had any effect and that exposure of EPI to agonist plus antagonist also had no effect. Moreover, none of the effects on EPI or ENDO were acute: incubation was required. Such incubation of EPI in Ang II (1) decreases the I to current density, (2) shifts the threshold for I to activation to more positive voltages, (3) shifts the voltage dependence of I to inactivation to more positive voltages, and (4) slows I to recovery from inactivation by Ͼ1 order of magnitude. Although the acute actions of Ang II on cardiac membrane currents in other species are mediated by activation of protein kinase C 18 and may include mitogen-activated protein kinase in the signaling cascade, 19 the signaling pathway that underlies the chronic action of Ang II on I to remains to be determined.
Chronic incubation of ENDO with losartan induces (1) an increase in I to density, (2) a more negative I to activation, (3) a more negative voltage dependence of I to inactivation, and (4) a dramatic speeding of I to recovery from inactivation. The resultant ENDO I to resembles that observed in normal EPI. This observation is all the more remarkable because it occurs in the absence of applied agonist. One plausible explanation is that tonic activation of the AT 1 receptor of normal ENDO myocytes occurs both in vivo and in the incubate and that the source of this tonic activation is an autocrine renin-angiotensin system present in the canine ventricular myocytes or in nonmyocyte cells that remain in the incubate.
If an autocrine renin-angiotensin system contributes to modulation of the T wave, then ENDO is likely exposed to a larger tonic influence of Ang II than EPI. This supposition is based on the observation that the conversion of ENDO I to to EPI I to involves AT 1 receptor blockade, whereas the converse action requires AT 1 receptor activation. This raises the possibility that these 2 cell types are normally under a chronically differing influence of the renin-angiotensin system. An autocrine renin-angiotensin system has already been reported in rat ventricular myocytes. [11] [12] [13] Either Ang II production, AT 1 receptor density, or coupling of the AT 1 receptor to its second messenger pathway might be more efficient in the ENDO, leading to a larger tonic effect. A higher activity of ACE in ENDO than in EPI has been reported in rat ventricle. 20 Also, angiotensin mRNA is higher in ENDO than in EPI in human ventricle. 21 Preliminary experiments with ACE inhibition in dogs have demonstrated alterations in the T wave vector. 22 The changes we observed in EPI and ENDO I to could have been caused by at least 3 alternatives: (1) a change in the molecular correlate of I to , (2) posttranslational modification of the channel protein, and (3) an auxiliary (␤) subunit. We consider each in turn. (1) Regarding a change in the molecular correlate of I to , in canine myocytes, I to has been identified as Kv4.3, although in control conditions, there also is some expression of Kv1.4. Because Kv1.4 recovers from inactivation much more slowly than Kv4.3, an isoform switch had to be given serious consideration. Our RNase protection assays demonstrated no change in transcript level for either channel with chronic incubation. Barring a dramatic difference between message and protein level, a change in the ␣ subunit of I to is a remote possibility. (2) Regarding posttransitional modification of the channel protein, our results in X laevis oocytes demonstrated that after incubation with Ang II, Kv4.3 exhibited a 2-fold slowing of recovery from inactivation. However, no change in the voltage dependence of activation or inactivation was observed. Possibly, the oocyte environment cannot reproduce that of the ventricular myocyte, and mammalian cells may allow for a more complete reconstruction of the observed effects. (3) Regarding an auxiliary (␤) subunit, it is known that ␤ subunits can alter the gating properties of ion channels. In cardiac myocytes, I Ks is a heteromultimer of KCNQ1 and minK. 23 KCNQ1 gates markedly more rapidly in the absence of minK. Recently, a ␤ subunit has been identified for the Kv4 family of ion channel subunits. 24 The channel recovers from inactivation more rapidly than in its absence. If this ␤ subunit were to underlie our results, its density should be higher in EPI than in ENDO, and this gradient should be altered by our long-term incubations.
One area in which our observations are relevant is cardiac memory, in which ECG T wave changes are associated with an altered transmural gradient for repolarization 6 and phenotypic expression is blocked by ACE inhibition or Ang II receptor blockade. 22 Another setting in which our observations may play a role is myocardial hypertrophy, whether pathological (eg, hypertension) or physiological (eg, postnatal left ventricular hypertrophy). Nonetheless, the importance of our findings to the evolution of repolarization in the heart and the morphology of the T wave remains to be established.
